These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8969650)

  • 1. Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood.
    Jung K; Nowak L; Lein M; Henke W; Schnorr D; Loening SA
    Clin Chem; 1996 Dec; 42(12):2043-5. PubMed ID: 8969650
    [No Abstract]   [Full Text] [Related]  

  • 2. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood.
    Jung K; Laube C; Lein M; Lichtinghagen R; Tschesche H; Schnorr D; Loening SA
    Clin Chem; 1998 May; 44(5):1060-2. PubMed ID: 9590387
    [No Abstract]   [Full Text] [Related]  

  • 3. What kind of specimen should be selected for determining tissue inhibitor of metalloproteinase-1 (TIMP-1) in blood?
    Jung K; Nowak L; Lein M; Henke W; Schnorr D; Loening SA
    Clin Chim Acta; 1996 Oct; 254(1):97-100. PubMed ID: 8894315
    [No Abstract]   [Full Text] [Related]  

  • 4. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
    Manicourt DH; Fujimoto N; Obata K; Thonar EJ
    Arthritis Rheum; 1995 Aug; 38(8):1031-9. PubMed ID: 7639798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metalloproteinases and their inhibitors: markers for malignant potential.
    Baker T; Tickle S; Wasan H; Docherty A; Isenberg D; Waxman J
    Br J Cancer; 1994 Sep; 70(3):506-12. PubMed ID: 8080738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of cyclic inhibitors of matrix metalloproteinases and TNF-alpha production.
    Xue CB; He X; Roderick J; DeGrado WF; Cherney RJ; Hardman KD; Nelson DJ; Copeland RA; Jaffee BD; Decicco CP
    J Med Chem; 1998 May; 41(11):1745-8. PubMed ID: 9599225
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
    Akiyama K; Shikata K; Sugimoto H; Matsuda M; Shikata Y; Fujimoto N; Obata K; Matsui H; Makino H
    Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):115-28. PubMed ID: 9090749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissue.
    Lein M; Nowak L; Jung K; Laube C; Ulbricht N; Schnorr D; Loening SA
    Ann N Y Acad Sci; 1999 Jun; 878():544-6. PubMed ID: 10415768
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
    Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
    Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood.
    Jung K
    J Rheumatol; 2007 Apr; 34(4):890-2; author reply 892. PubMed ID: 17407248
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease.
    Kossakowska AE; Medlicott SA; Edwards DR; Guyn L; Stabbler AL; Sutherland LR; Urbanski SJ
    Ann N Y Acad Sci; 1999 Jun; 878():578-80. PubMed ID: 10415778
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue.
    Kubota T; Nomura T; Takahashi T; Hara K
    Arch Oral Biol; 1996 Mar; 41(3):253-62. PubMed ID: 8735011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment.
    Zucker S; Lysik RM; Zarrabi HM; Moll U; Tickle SP; Stetler-Stevenson W; Baker TS; Docherty AJ
    Ann N Y Acad Sci; 1994 Sep; 732():248-62. PubMed ID: 7978797
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.
    Benyon RC; Iredale JP; Goddard S; Winwood PJ; Arthur MJ
    Gastroenterology; 1996 Mar; 110(3):821-31. PubMed ID: 8608892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
    Reynolds JJ; Meikle MC
    J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of matrix metalloproteinases and their inhibitor in the articular disc of the craniomandibular joint of the rabbit.
    Breckon JJ; Hembry RM; Reynolds JJ; Meikle MC
    Arch Oral Biol; 1996 Apr; 41(4):315-22. PubMed ID: 8771322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
    Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
    Hanessian S; Moitessier N; Gauchet C; Viau M
    J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.